Literature DB >> 19665939

The value of palliative surgery for metastatic spinal disease: satisfaction of patients and their families.

Shunsuke Fujibayashi1, Masashi Neo, Koichi Miyaki, Takeo Nakayama, Takashi Nakamura.   

Abstract

BACKGROUND CONTEXT: Although there have been several studies in which the surgical outcomes were evaluated by pain reduction or neurological improvement, there have been few studies focused on the quality of life (QOL) of the patients after the surgery. We considered that the most important consideration in palliative surgery was to respect the wishes of patients and their families, which are likely to be influenced by the patients' QOL for their limited life span.
PURPOSE: To evaluate the value of palliative surgery for spinal metastasis and to identify the factors predicting satisfaction of patients and their families after the surgery. STUDY
DESIGN: Questionnaire-based survey of palliative surgery for spinal metastasis. PATIENT SAMPLE: Seventy-one consecutive patients who had undergone palliative surgery and their families. OUTCOME MEASURES: Survival period after surgery, neurological status, ambulatory period, pain scale, and satisfaction of patients and their families.
METHODS: The QOL of the patients after surgery was evaluated by analyzing the satisfaction and related parameters of patients and their families. Questionnaires were sent to 71 consecutive patients who had undergone palliative surgery for spinal metastasis. To identify the factors predicting satisfaction of patients and their families, multivariate logistic regression analyses were performed.
RESULTS: Questionnaires were successfully delivered to 71 patients or their families. Full responses were collected from 37 patients, giving an overall response rate of 52.2%. Overall, 80% of patients were satisfied with the results of the surgical treatment. Age (below 65 years) and neurological improvement after surgery were significant predictors of patient's satisfaction. Pain reduction and the continued survival of the patient were significant predictors of family member's satisfaction.
CONCLUSIONS: These results strongly suggested that palliative surgery is a valuable treatment for metastatic spinal disease. Younger patients were more likely to want active treatment and to seek any functional improvement that contributed to an improved QOL in their limited life span. Pain control and the length of patient survival were important factors for people caring for patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19665939     DOI: 10.1016/j.spinee.2009.06.016

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  8 in total

1.  The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases.

Authors:  Rachit Kumar; Anick Nater; Ahmed Hashmi; Sten Myrehaug; Young Lee; Lijun Ma; Kristin Redmond; Simon S Lo; Eric L Chang; Albert Yee; Charles G Fisher; Michael G Fehlings; Arjun Sahgal
Journal:  Neurooncol Pract       Date:  2015-07-27

2.  Independent predictors of complication following surgery for spinal metastasis.

Authors:  Darryl Lau; Matthew R Leach; Khoi D Than; John Ziewacz; Frank La Marca; Paul Park
Journal:  Eur Spine J       Date:  2013-02-08       Impact factor: 3.134

3.  Surgical management with radiation therapy for metastatic spinal tumors located on cervicothoracic junction : a single center study.

Authors:  Ho-Young Park; Sun-Ho Lee; Se-Jun Park; Eun-Sang Kim; Chong-Suh Lee; Whan Eoh
Journal:  J Korean Neurosurg Soc       Date:  2015-01-31

4.  Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution.

Authors:  Chia-Lin Tseng; Wietse Eppinga; Raphaele Charest-Morin; Hany Soliman; Sten Myrehaug; Pejman Jabehdar Maralani; Mikki Campbell; Young K Lee; Charles Fisher; Michael G Fehlings; Eric L Chang; Simon S Lo; Arjun Sahgal
Journal:  Global Spine J       Date:  2017-04-06

Review 5.  Symptomatic spinal metastasis: A systematic literature review of the preoperative prognostic factors for survival, neurological, functional and quality of life in surgically treated patients and methodological recommendations for prognostic studies.

Authors:  Anick Nater; Allan R Martin; Arjun Sahgal; David Choi; Michael G Fehlings
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

6.  Analysis of the predictive role and new proposal for surgical strategies based on the modified Tomita and Tokuhashi scoring systems for spinal metastasis.

Authors:  Junhyung Kim; Sun-Ho Lee; Se-Jun Park; Sung-Soo Chung; Eun-Sang Kim; Whan Eoh; Chong-Suh Lee
Journal:  World J Surg Oncol       Date:  2014-08-01       Impact factor: 2.754

7.  Patterns of Treatment for Metastatic Pathological Fractures of the Spine: The Efficacy of Each Treatment Modality.

Authors:  Jae Hwan Cho; Jung-Ki Ha; Chang Ju Hwang; Dong-Ho Lee; Choon Sung Lee
Journal:  Clin Orthop Surg       Date:  2015-11-13

8.  Patient satisfaction with treatment outcomes after surgery and/or radiotherapy for spinal metastases.

Authors:  Anne L Versteeg; Arjun Sahgal; Norio Kawahara; Laurence D Rhines; Daniel M Sciubba; Michael H Weber; Áron Lazary; Michael G Fehlings; James M Schuster; Michelle J Clarke; Paul M Arnold; Stefano Boriani; Chetan Bettegowda; Ziya L Gokaslan; Charles G Fisher
Journal:  Cancer       Date:  2019-09-06       Impact factor: 6.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.